Drug intelligence / Profile preview

Obex

Development stage
Unknown
Lead developer
Laboratorios Catalysis
Modality
Small Molecules
Administration
Oral
01

Overview

Obex is a multi-ingredient dietary supplement developed by Laboratorios Catalysis, primarily indicated for the management of overweight and obesity. The formulation consists of a synergistic blend of natural extracts, including *Caralluma fimbriata* for appetite suppression, *Phaseolus vulgaris* (white kidney bean) extract to inhibit carbohydrate absorption via alpha-amylase inhibition, and Acai berry extract for its antioxidant properties. It also contains inulin to support gut health, L-carnitine to facilitate fat metabolism, and various amino acids (L-arginine, L-methionine, L-ornithine) and vitamins to improve insulin sensitivity and metabolic homeostasis. Clinical evidence from Phase III trials suggests that Obex, when combined with lifestyle modifications, significantly aids in weight loss, reduces waist circumference, and improves lipid profiles and insulin resistance markers without significant adverse effects.

Brand names
Obex
02

Targets

AMY (Pancreatic alpha-amylase)INSR (Insulin receptor)

Beyond the preview

Go deeper on Obex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Obex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call